Insurers allegedly denying eligible patients access to pricey new Hepatitis C drugs will have their day in court.
The health insurance giant hasn't made any gains over the past year. Here's why it could be poised for a fall.
Why the big PBM's stock might be less risky than it's been in a long time.
Investors bid up shares today after the company reported record quarterly results.
Record quarterly revenue showed continued strong demand for healthcare staffing.
The pharmacy benefits manager says Anthem is "certainly not entitled" to $3 billion in additional savings.
Savings demands by its largest customer could dent the pharmacy benefits manager's earnings in 2016 and beyond.
The nation's largest health insurers have yet to get a handle on medical expenses of the Affordable Care Act's individual insurance plans after two years, but year three could be the year they make money.
This is a key question for income investors, and the answer is less clear than the health insurer's history would suggest.
Anthem's management explains how the business is doing and what we can expect from here.